Filing Details
- Accession Number:
- 0001104659-21-062421
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-05-06 13:00:00
- Reporting Period:
- 2021-05-04
- Accepted Time:
- 2021-05-06 16:25:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1828185 | Vaccitech Plc | VACC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1856079 | Plc Innovation Sciences Oxford | 46 Woodstock Road Oxford X0 OX2 6HT | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2021-05-04 | 4,832,142 | $0.00 | 4,832,142 | No | 4 | C | Direct | |
| Ordinary Shares | Acquisiton | 2021-05-04 | 1,704,444 | $0.00 | 6,536,586 | No | 4 | C | Direct | |
| Ordinary Shares | Acquisiton | 2021-05-04 | 1,661,184 | $0.00 | 8,197,770 | No | 4 | C | Direct | |
| American Depositary Shares | Acquisiton | 2021-05-04 | 600,000 | $17.00 | 8,797,770 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Ordinary Shares | Disposition | 2021-05-04 | 4,832,142 | $0.00 | 4,832,142 | $0.00 |
| Ordinary Shares | Series A redeemable convertible preferred shares | Disposition | 2021-05-04 | 1,704,444 | $0.00 | 1,704,444 | $0.00 |
| Ordinary Shares | Series B preferred shares | Disposition | 2021-05-04 | 1,661,184 | $0.00 | 1,661,184 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Ordinary Shares may be represented by American Depositary Shares, each of whicb currently represents one Ordinary Share.
- Each American Depositary Share represents one ordinary share.
- Each ordinary share, Series A redeemable convertible preferred share and Series B preferred share were converted into Ordinary Shares on a one-for-309 basis immediately prior to the closing ofVaccilech plc's (the "Issuer") initial public offering without payment of consideration. None of the ordinary shares, Series A redeemable convertible preferred share and Series B preferred shares had an expiration date.
- The number of shares reported reflects the conversion set out in Footnote (3).
Billionaire Hedge Funds
